Black excellence and community was the theme of the night at the annual Fifteen Percent Pledge Gala with some of the biggest stars turning out to support Black-owned businesses and honor Tina Knowles.

Feb. 8 (UPI) --Duchess of Sussex Meghan Markle helped honor Tina Knowles, pop music legend Beyonce's mother, at the Fifteen Percent Pledge fundraiser gala at Paramount Studios in Los Angeles on ...

The event will feature honorees, music, food, and programming focused on entrepreneurship and community building. Designer Aurora James and her organization, Fifteen Percent Pledge, will honor Tina ...

It was a glitzy, glamorous, gaiety-filled evening at the 2026 Fifteen Percent Pledge fundraising gala in Los Angeles last night. Meghan Markle, the Duchess of Sussex, chose to fly solo and match the ...

If you've ever checked the weather on your phone with an app like Weather Up — or just watched it on TV — then you've probably seen the forecasters talk about the "chance of rain" or "chance of snow." ...

Bankers argue that the proposal is often framed as consumer‑friendly, but consumers could face reduced access to affordable credit. Some 47 percent of credit cardholders report having a credit card ...

On Tuesday the American Cancer Society (ACS) released its annual report on cancer statistics in the U.S., and it offered a rare bit of good news: the proportion of people who were alive at least five ...

– Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing ...

L-R: Nick Kroll, Sam Richardson, Jason Mantzoukas, Vanessa Bayer (inset) Gabe Liedman Getty/Atiba Jefferson/Matt Doyle/Getty/Kim Newmoney EXCLUSIVE: Nick Kroll, co-creator and star of Netflix‘s ...

Mr. Khan is the C.E.O. of Khan Academy and the vision steward at TED, both nonprofits that provide free online education for more than 200 million learners globally. On my way to meet a friend in ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...